|The Global Fund|
GLOBAL FUND HIV/AIDS ROUND 4 – SIERRA LEONE
Global Fund HIV/AIDS – Sierra Leone came into existence in May 2005 following approval and signing of a contractual agreement between the Government of Sierra Leone and the Global Fund Headquarters in Geneva.
The Global Fund was set up as a funding agency to complement already existing programmes such as the Sierra Leone HIV/AIDS Response Project (SHARP) funded by the World Bank.
The Global Fund contract will last for five years – with an initial 1st phase of two years and a second phase of three years.
The overall goal of Global Fund Sierra Leone is to develop and scale up a comprehensive National Response to HIV/AIDS that includes adequate Prevention, Treatment, Care and Support for those affected.
The National Aids Secretariat (NAS) is the Principal Recipient, supervised by the Country Coordinating Mechanism (CCM).
NAS, the Principal Recipient (PR), has fifty-one (51) implementing partners known as Sub-Recipients (SRs). They include:
Global Fund Sierra Leone is implementing activities for both Round 4 & Round 6. Round 4 is in its last year, while Round 6 has three more years. Targets for each quarter are successfully achieved.
Monitoring and supervision of activities are ongoing.
Staff of the Project has been recruited, while logistics and supplies have been procured and distributed to enhance activities.
Coverage achievement levels stand as follows:
Round 4 ------- A
Round 6 ------- B
Call for Proposal for the Implementation of the kfw Impact Mitigation Component of the HIV/AIDS Prevention program III (HAPP III)
Deadline: 3:PM October 10th, 2013
The Government of Sierra Leone has received a grant from the German Government through KfW to the tune of EUR 6 Million Euro to finance sexual reproductive health Programme for the period 2013 - 2017. The programme includes HIV prevention through social marketing of condoms and behaviour change communication measures as well as Impact Mitigation Fund (IMF) to support civil society organisations to mitigate the impact of HIV/AIDS and gender-based violence (GBV) including Female Genital Mutilation.